The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Parkinson Disease Neuropathology: Later-Developing Dementia and Loss of the Levodopa Response
Abstract
OBJECTIVE: To investigate the neuropathologic substrate for dementia occurring late in Parkinson disease (PD). DESIGN: We identified 13 patients with a clinical diagnosis of PD who experienced dementia at least 4 years after parkinsonism onset (mean, 10.5 years) and subsequently underwent postmortem examination. Despite levodopa therapy, 9 patients later became severely impaired and nonambulatory, requiring total or near-total care; this included 4 patients treated with 1200 mg/d or more of levodopa (with carbidopa), which was consistent with loss of the levodopa response. These 13 patients were compared with 9 patients clinically diagnosed as having PD, but without dementia, who had undergone autopsies. RESULTS: Twelve of 13 PD patients with dementia had findings of diffuse or transitional Lewy body disease as the primary pathologic substrate for dementia; 1 had progressive supranuclear palsy. This pathology also apparently accounted for the levodopa refractory state. Among the 12 PD patients with dementia, mean and median Lewy body counts were increased nearly 10-fold in neocortex and limbic areas compared with PD patients without dementia (P< or =.002). Alzheimer pathology was modest. Only one patient met the criteria defined by the National Institute on Aging and the Reagan Institute Working Group on the Diagnostic Criteria for the Neuropathologic Assessment of Alzheimer's Disease for "intermediate probability of Alzheimer's disease." There were, however, significant correlations between neocortical Lewy body counts and senile plaques as well as neurofibrillary tangles. Senile plaque counts did not significantly correlate with tangle counts in any of the analyzed nuclei. Arteriolar disease may have contributed to the clinical picture in 2 patients. CONCLUSIONS: Diffuse or transitional Lewy body disease is the primary pathologic substrate for dementia developing later in PD. This same pathologic substrate seemed to account for end-stage, levodopa refractory parkinsonism. The occurrence of Alzheimer pathology was modest, but was highly correlated with Lewy body pathology, suggesting common origins or one triggering the other.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationSpillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M. M., Hofstetter, R., Klauber, M., et al. (1990) · Neurology · doi:10.1212/wnl.40.1.1 · Cited by 1,068
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981
A Clinicopathologic Study of 100 Cases of Parkinson's Disease
Hughes, A. J., Daniel, S. E., Blankson, S., & Lees, A. J. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540020018011 · Cited by 956
Risk of dementia in Parkinson’s disease: A community-based, prospective study
Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A., Nielsen, H., & Kragh–Sørensen, P. (2001) · Neurology · doi:10.1212/wnl.56.6.730 · Cited by 721
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease
Hurtig, H. I., Trojanowski, J. Q., Galvin, J., Ewbank, D., Schmidt, M. L., Lee, V. M. Y., Clark, C. M., Glosser, G., Stern, M. B., Gollomp, S. M., et al. (2000) · Neurology · doi:10.1212/wnl.54.10.1916 · Cited by 601
Perry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A., Blessed, G., Fairbairn, A., Tomlinson, B. E., & Perry, R. H. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.413 · Cited by 571
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 534
Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies
McKeith, I. G., Ballard, C. G., Perry, R. H., Ince, P. G., O’Brien, J. T., Neill, D., Lowery, K., Jaros, E., Barber, R., Thompson, P., et al. (2000) · Neurology · doi:10.1212/wnl.54.5.1050 · Cited by 459
Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations
Boller, F., Mizutani, T., Roessmann, U., & Gambetti, P. (1980) · Annals of Neurology · doi:10.1002/ana.410070408 · Cited by 451 · cited 1×
“In the last quarter of the 20th century, more than 20 investigations addressed this issue (Table 2).(19-40) Among these publications, there has been no consensus whether this dementia is primarily a cortical or subcortical process or whether Alzheimer disease (AD) or Lewy body disease is the primary contributor.”
BackgroundLewy bodies are ubiquitinated: A light and electron microscopic immunocytochemical study
Kuzuhara, S., Mori, H., Izumiyama, N., Yoshimura, M., & Ihara, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00687787 · Cited by 410
Mayeux, R. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530290076015 · Cited by 383
A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease
Hughes, T. A., Ross, H. F., Musa, S., Bhattacherjee, S., Nathan, R. N., Mindham, R. H. S., & Spokes, E. G. S. (2000) · Neurology · doi:10.1212/wnl.54.8.1596 · Cited by 372
Mattila, P. M., Rinne, J. O., Helenius, H., Dickson, D. W., Röyttä, M., & Mattila, P. M. (2000) · Acta Neuropathologica · doi:10.1007/s004019900168 · Cited by 361
Self-citationA Short Test of Mental Status: Description and Preliminary Results
KOKMEN, E., NAESSENS, J. M., & OFFORD, K. P. (1987) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61905-3 · Cited by 350
Dementia in Parkinson disease: A neuropathologic study
Hakim, A. M., & Mathieson, G. (1979) · Neurology · doi:10.1212/wnl.29.9_part_1.1209 · Cited by 333
Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra
Rinne, J. O., Mlic, J. R., Paljärvi, L., & Rinne, U. K. (1989) · Annals of Neurology · doi:10.1002/ana.410260107 · Cited by 331
HOW COMMON IS DEMENTIA IN PARKINSON'S DISEASE?
Brown, R. G., & Marsden, C. D. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92807-1 · Cited by 320 · cited 6×
“We anticipated that the neuropathologic basis for this dementia should be apparent and may be fairly uniform if (1) we restricted our PD patients to those in whom parkinsonism preceded dementia by at least 4 years and (2) the histologic techniques included -synuclein immunohistochemical analysis.”
BackgroundMethodInfluentialClinical subtypes of dementia of the Alzheimer type
Chui, H. C., Teng, E. L., Henderson, V. W., & Moy, A. C. (1985) · Neurology · doi:10.1212/wnl.35.11.1544 · Cited by 296
Dickson, D. W., Ruan, D., Crystal, H., Mark, M. H., Davies, P., Kress, Y., & Yen, S.-H. (1991) · Neurology · doi:10.1212/wnl.41.9.1402 · Cited by 295
Self-citationFrequency of Dementia in Parkinson Disease
Aarsland, D., Tandberg, E., Larsen, J. P., & Cummings, J. L. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550060082020 · Cited by 280
Dementia in idiopathic Parkinson's disease: A neuropathological study of 32 cases
Gaspar, P., & Gray, F. (1984) · Acta Neuropathologica · doi:10.1007/bf00695605 · Cited by 275
Overview of morphological changes in Parkinson's disease.
Jellinger, K. A. (1987) · PubMed · Cited by 272
The Frequency and Associated Risk Factors for Dementia in Patients With Parkinson's Disease
Marder, K., Tang, M.-X., Cote, L., Stern, Y., & Mayeux, R. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310069018 · Cited by 268
Neuropsychological prediction of dementia in Parkinson's disease
Mahieux, F., Fenelon, G., Flahault, A., Manifacier, M.-J., Michelet, D., & Boller, F. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.2.178 · Cited by 219
An Estimate of the Prevalence of Dementia in Idiopathic Parkinson's Disease
Mayeux, R., Stern, Y., Rosenstein, R., Marder, K., Hauser, A., Cote, L., & Fahn, S. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520270034017 · Cited by 190
Gwinn-Hardy, K., Mehta, N. D., Farrer, M., Maraganore, D., Muenter, M., Yen, S. H., Hardy, J., & Dickson, D. W. (2000) · Acta Neuropathologica · doi:10.1007/s004010051177 · Cited by 184
Self-citationPATHOLOGICAL BASIS FOR NEUROTRANSMITTER CHANGES IN PARKINSON'S DISEASE
MANN, D. M. A., & YATES, P. O. (1983) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1983.tb00320.x · Cited by 164
The locus ceruleus and dementia in Parkinson's disease
Zweig, R. M., Cardillo, J. E., Cohen, M., Giere, S., & Hedreen, J. C. (1993) · Neurology · doi:10.1212/wnl.43.5.986 · Cited by 161
An estimate of the incidence of dementia in idiopathic Parkinson's disease
Mayeux, R., Chen, J., Mirabello, E., Marder, K., Bell, K., Dooneief, G., Cote, L., & Stern, Y. (1990) · Neurology · doi:10.1212/wnl.40.10.1513 · Cited by 160
Extrapyramidal signs in Alzheimer's disease
Mölsä, P. K., Marttila, R. J., & Rinne, U. K. (1984) · Neurology · doi:10.1212/wnl.34.8.1114 · Cited by 150
Rajput, A. H., Offord, K. P., Beard, C. M., & Kurland, L. T. (1987) · Neurology · doi:10.1212/wnl.37.2.226 · Cited by 144
Pathologic Correlates of Dementia in Parkinson's Disease
Chui, H. C., Mortimer, J. A., Slager, U. T., Zarow, C., Bondareff, W., & Webster, D. D. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520100013007 · Cited by 142
A controlled, longitudinal study of dementia in Parkinson's disease.
Biggins, C. A., Boyd, J. L., Harrop, F. M., Madeley, P., Mindham, R. H. S., Randall, J. I., & SPOKES, E. G. S. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.7.566 · Cited by 135
Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease
Mattila, P. M., Röyttä, M., Torikka, H., Dickson, D. W., & Rinne, J. O. (1998) · Acta Neuropathologica · doi:10.1007/s004010050843 · Cited by 133
Self-citationBreteler, M. M. B., de Groot, R. R. M., van Romunde, L. K. J., & Albert Hofman, D. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117597 · Cited by 121
Heyman, A., Fillenbaum, G. G., Gearing, M., Mirra, S. S., Welsh-Bohmer, K. A., Peterson, B. L., & Pieper, C. F. (1999) · Neurology · doi:10.1212/wnl.52.9.1839 · Cited by 109
Braak, H., & Braak, E. (1990) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02251245 · Cited by 103
Tison, F., Dartigues, J.-F., Auriacombe, S., Letenneur, L., Boller, F., & Alpérovitch, A. (1995) · Neurology · doi:10.1212/wnl.45.4.705 · Cited by 90
Morphological substrates of dementia in parkinsonism A critical update
Jellinger, K. A. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_6 · Cited by 85
Dementia and cognitive impairment in Parkinson's disease.
Girotti, F., Soliveri, P., Carella, F., Piccolo, I., Caffarra, P., Musicco, M., & CARACENI, T. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.12.1498 · Cited by 85
Sutcliffe, R. L. G., Prior, R., Mawby, B., & McQuillan, W. J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1985.tb00886.x · Cited by 77
de Vos, R. A. I., Jansen, E. N. H., Stam, F. C., Ravid, R., & Swaab, D. F. (1995) · Clinical Neurology and Neurosurgery · doi:10.1016/0303-8467(94)00060-j · Cited by 75
Dementia in Parkinson's Disease
Friedman, A., & Barcikowska, M. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106688 · Cited by 74
Haroutunian, V. H., Serby, M., Purohit, D. P., Perl, D. P., Marin, D. B., Lantz, M., Mohs, R. C., & Davis, K. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.8.1145 · Cited by 71
Brown, D. F., Risser, R. C., Bigio, E. H., Tripp, P., Stiegler, A., Welch, E., Eagan, K. P., Hladik, C. L., & White, C. L. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199810000-00007 · Cited by 69
Tyrrell, P. J., Sawle, G. V., Ibanez, V., Bloomfield, P. M., Leenders, K. L., Frackowiak, R. S. J., & Rossor, M. N. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120062011 · Cited by 68
Amyloid β‐peptide and the dementia of Parkinson's diease
Jendroska, K., Lees, A. J., Poewe, W. H., & Daniel, S. E. (1996) · Movement Disorders · doi:10.1002/mds.870110609 · Cited by 49
Dementia in idiopathic Parkinson's disease: Variables associated with its occurrence in 203 patients
Elizan, T. S., Sroka, H., Maker, H. S., Smith, H., & Yahr, M. D. (1986) · Journal of Neural Transmission · doi:10.1007/bf01249089 · Cited by 45
Alzheimer Disease and the Dementia of Parkinson Disease: Comparative Investigations
Mahler, M. E., & Cummings, J. L. (1990) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199040300-00002 · Cited by 41
Pathological basis for dementia in elderly patients with idiopathic Parkinson's disease.
Yoshimura, M. (1988) · PubMed · Cited by 39
Dementia in Parkinson's disease. Morphometric data.
Duyckaerts, C. J., Gaspar, P., Costa, C. C., et al. (1993) · PubMed · Cited by 32
Dementia Associated With Lewy Bodies
Weiner, M. (1999) · Archives of Neurology · doi:10.1001/archneur.56.12.1441 · Cited by 29
Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia.
Xuereb, J. H., Tomlinson, B. E., Irving, D., Perry, R. H., Blessed, G., & Perry, E. K. (1990) · PubMed · Cited by 23
Neocortical changes in Parkinson's disease, revisited.
Sugiyama, H., Hainfellner, J. A., Yoshimura, M., & Budka, H. (1994) · PubMed · Cited by 21
Cited by
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationDiagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Self-citationNon-motor symptoms of Parkinson's disease: diagnosis and management
Chaudhuri, K. R., Healy, D. G., & Schapira, A. H. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70373-8 · Cited by 2,807
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Metadata
- Authors
- Apaydin, H., Ahlskog, J. E., Parisi, J. E., Boeve, B. F., & Dickson, D. W.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2002-01-01
- Volume
- 59
- Issue
- 1
- Pages
- 102
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2089686995
- Cited by
- 399
- References
- 61
- FWCI
- 21.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.